Biology Reference
In-Depth Information
[7] Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic inter-
action between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet
2002;31(4):429-34.
[8] Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human
disease. Semin Immunol 2008;20(6):343-52.
[9] Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23:225-74.
[10] Dimasi N, Biassoni R. Structural and functional aspects of the Ly49 natural killer cell
receptors. Immunol Cell Biol 2005;83(1):1-8.
[11] Dam J, Guan R, Natarajan K, Dimasi N, Chlewicki LK, Kranz DM, et al. Variable MHC
class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal
structure of Ly49C bound to H-2K(b). Nat Immunol 2003;4(12):1213-22.
[12] Nakamura MC, Linnemeyer PA, Niemi EC, Mason LH, Ortaldo JR, Ryan JC, et al. Mouse
Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med
1999;189(3):493-500.
[13] George TC, Ortaldo JR, Lemieux S, Kumar V, Bennett M. Tolerance and alloreactivity of
the Ly49D subset of murine NK cells. J Immunol 1999;163(4):1859-67.
[14] Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of
natural killer cells by host major histocompatibility complex class I molecules. Nature
2005;436(7051):709-13.
[15] Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell
receptors involved in MHC class I recognition are disulfide-linked heterodimers of
CD94 and NKG2 subunits. J Immunol 1996;157(11):4741-5.
[16] Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL. Kinetics and
peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and
the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999;18(15):4250-60.
[17] Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, et al. LAIR-1, a
novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity
1997;7(2):283-90.
[18] Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, et al. A novel immuno-
globulin superfamily receptor for cellular and viral MHC class I molecules. Immunity
1997;7(2):273-82.
[19] Biassoni R, Bottino C, Cantoni C, Moretta A. Human natural killer receptors and their
ligands. Curr Protoc Immunol 2002; Chapter 14:Unit 14.10.
[20] Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, et al. Recognition of
haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.
Nature 2001;409(6823):1055-60.
[21] Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, et al.
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile
and dengue viruses with NK cells. J Immunol 2009;183(4):2610-21.
[22] Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK recep-
tors. Trends Immunol 2005;26(4):221-6.
[23] Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immu-
nol 2008;9(5):495-502.
[24] Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and
costimulation of resting human natural killer cells. Immunol Rev 2006;214:73-91.
[25] Colucci F, Rosmaraki E, Bregenholt S, Samson SI, Di Bartolo V, Turner M, et al. Func-
tional dichotomy in natural killer cell signaling: Vav1-dependent and -independent
mechanisms. J Exp Med 2001;193(12):1413-24.
[26] Huntington ND, Xu Y, Nutt SL, Tarlinton DM. A requirement for CD45 distinguishes
Ly49D-mediated cytokine and chemokine production from killing in primary natural
killer cells. J Exp Med 2005;201(9):1421-33.
[27] Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol
2006;6(7):520-31.
[28] Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell edu-
cation by inhibitory receptors for MHC class I. Immunity 2006;25(2):331-42.
[29] Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo DL, et al. Mouse NK cell-mediated
rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset
licensing. Blood 2012;119(6):1590-8.
[30] Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, et al. A subpopula-
tion of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is
developmentally immature. Blood 2007;110(2):578-86.
[31] Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response
to cytomegalovirus infection. Nat Immunol 2010;11(4):321-7.
[32] Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, et al. KIR and HLA genotypes
are associated with disease progression and survival following autologous hematopoietic
stem cell transplantation for high-risk neuroblastoma. Clin Cancer Res 2009;15(23):7330-4.
351
Search WWH ::
Custom Search